Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LCID✓SelectedUSD · LCIDGSK vs LCID performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs LCID

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.4%
LCID return
-93.4%
Excess return
+157.8%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioLCIDExcessAlpha
1D-0.1%-5.2%+5.2%+0.1%
7D-1.3%-22.2%+20.9%-0.6%
30D+2.7%-10.5%+13.3%+2.9%
3M+2.7%-55.0%+57.7%+4.6%
6M+3.3%-53.6%+57.0%+4.7%
YTD+6.5%-73.5%+80.0%+8.9%
1Y+10.7%-80.3%+90.9%+13.6%
3Y+64.4%-93.5%+157.8%+70.5%
All+64.4%-93.4%+157.8%+70.5%

Cumulative growth

Daily Returns

Daily percentage return beside LCID.

Daily Out/Under-Performance

Portfolio return minus LCID return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LCID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded LCID wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling